ApprovalTrail

Drug · DIN 02452340

COTELLIC

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since April 6, 2016; first marketed April 6, 2016.
Drug Identification Number (DIN)
02452340
Company (DIN owner)
Hoffmann-La Roche LimitedMississauga, Ontario, Canada
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Cobimetinib L01EE02
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
COBIMETINIB (COBIMETINIB FUMARATE)20 MG

Notices of Compliance

Health Canada approvals that name this DIN.